A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours

To determine the maximum tolerated doses (MTDs) and dose-limiting toxicities (DLTs) of pegylated liposomal doxorubicin (PLD), paclitaxel (PCX) and gemcitabine (GEM) combination administered biweekly in patients with advanced solid tumours. Twenty-two patients with advanced-stage solid tumours were t...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bozionelou, V, Vamvakas, L, Pappas, P, Agelaki, S, Androulakis, N, Kalykaki, A, Nikolaidou, M, Kentepozidis, N, Giassas, S, Marselos, M, Georgoulias, V, Mavroudis, D
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2007
Onderwerpen:
Clinical Study
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2359662/
https://ncbi.nlm.nih.gov/pubmed/17551496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603832
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items